Eagle Pharmaceuticals Inc. (EGRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

1,962,070 $10,987,592 +56% 0.64%
2. 1,211,509 $6,784,451 +3% 2.11%
3.
Nantahala Capital ManagementCALL

Wilmot B. Harkey And Daniel Mack

1,000,000 $5,600,000 0.32%
4. 696,797 $3,902,063 -21% 0%
5. 244,250 $1,367,800 -27% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$55.45 350 Officer 700 2017-08-16 Filing
$50.09 1,584 Director 971,000 2017-08-09 Filing
$49.21 15,206 Director 969,416 2017-08-09 Filing
$48.06 3,610 Director 954,210 2017-08-09 Filing
$71.49 350 Officer 350 2017-06-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$13.87 10,694 Large Shareholder, Officer, Director 545,447 2023-11-02 Filing
$13.82 10,925 Large Shareholder, Officer, Director 556,141 2023-11-01 Filing
$15.11 710 Large Shareholder, Officer, Director 567,066 2023-10-03 Filing
$14.41 10,024 Large Shareholder, Officer, Director 567,776 2023-10-03 Filing
$15.23 9,511 Large Shareholder, Officer, Director 577,800 2023-10-02 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 984,908 $5,151,070 0%
2. 775,525 $4,055,996 0%
3. 745,080 $3,896,768 0.05%
4. 638,124 $3,337,389 0%
5. 296,864 $1,552,599 0%
News See All